Jagat R Kanwar
Professor, Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research, School of Medicine
Deakin University, Australia
Associate Professor Jagat Kanwar, group leader of the Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research in Nanomedicine (LIMBR-setup in 2007 after A/Prof. Kanwars movement to Deakin University), has a national and international reputation in investigating fundamental and applied molecular aspects of cancer and chronic inflammation. The group carries out research in the areas of national priority such cancer, chronic inflammatory diseases (ageing) and molecular nutrition (complementary alternative medicine) with milk/herbs bioactives as immunomodulators. Additionally by investigating bioactives role in gut biology, and immune health, LIMBR seeks to commercially exploit dairy bioactives for human health and the development of functional food ingredients, health supplements and neutraceutical and/or pharmaceutical grade immunotherapeutics. Apart from industry funded projects our research is also focused on siRNA, miRNA, aptamer, and immunoliposomes technology and disease target drug discovery. LIMBR provides high quality research training and education to undergraduate and postgraduate students which, in turn, strengthen Deakins strategic research and academic priorities, helping our students keep in pace with the emerging concepts of science and technology.
Immunology & Cell Biology, Nanomedicine based drug delivery, Cancer and Neuroprotection